Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
74.94
+1.89 (2.59%)
At close: Mar 9, 2026, 4:00 PM EDT
74.71
-0.23 (-0.31%)
After-hours: Mar 9, 2026, 6:59 PM EDT

Apogee Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
131.55141.79118.32151.89
Short-Term Investments
598.64378.86277.14-
Cash & Short-Term Investments
730.19520.65395.46151.89
Cash Growth
40.24%31.66%160.36%-
Other Receivables
5.964.71.21-
Receivables
5.964.71.21-
Prepaid Expenses
4.62.621.740.11
Other Current Assets
0.611.74-0.06
Total Current Assets
741.36529.71398.41152.06
Property, Plant & Equipment
14.3813.322.59-
Long-Term Investments
172.73210.42--
Other Long-Term Assets
8.670.50.4-
Total Assets
937.13753.95401.4152.06
Accounts Payable
1.221.072.140.42
Accrued Expenses
23.1824.2617.319.56
Current Portion of Leases
3.53.231.1-
Total Current Liabilities
27.9128.5620.569.98
Long-Term Leases
5.358.60.93-
Total Liabilities
33.2537.1621.499.98
Common Stock
00-2.25
Additional Paid-In Capital
1,4651,022503.35-
Retained Earnings
-561.76-305.92-123.77-39.79
Comprehensive Income & Other
1.080.920.332.14
Total Common Equity
903.88716.79379.91-35.39
Shareholders' Equity
903.88716.79379.91142.08
Total Liabilities & Equity
937.13753.95401.4152.06
Total Debt
8.8511.832.03-
Net Cash (Debt)
894.07719.24393.43151.89
Net Cash Growth
24.31%82.82%159.02%-
Net Cash Per Share
14.7313.0315.7361.69
Filing Date Shares Outstanding
68.8558.0948.525
Total Common Shares Outstanding
68.458.0648.525
Working Capital
713.45501.15377.85142.08
Book Value Per Share
13.2112.357.83-7.08
Tangible Book Value
903.88716.79379.91-35.39
Tangible Book Value Per Share
13.2112.357.83-7.08
Machinery
4.221.29--
Leasehold Improvements
3.080.86--
Source: S&P Capital IQ. Standard template. Financial Sources.